Issue 6/2012
Content (8 Articles)
Value of Information and Pricing New Healthcare Interventions
Andrew R. Willan, Simon Eckermann
A Critical Review of Model-Based Economic Studies of Depression
Hossein Haji Ali Afzali, Jonathan Karnon, Jodi Gray
Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura
Dwayne Boyers, Xueli Jia, David Jenkinson, Graham Mowatt
Cost Effectiveness of Quetiapine in Patients with Acute Bipolar Depression and in Maintenance Treatment after an Acute Depressive Episode
Mattias Ekman, Peter Lindgren, Carolin Miltenburger, Genevieve Meier, Julie C. Locklear, Mary Lou Chatterton
The Lack of Impact of Quality-of-Life Measures in Schizophrenia: A Shared Responsibility?
Laurent Boyer, Pascal Auquier
Erratum to Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study
Laura T. Pizzi, Amy Talati, Eric Gemmen, Naomi V. Dahl, Thomas J. Bunz, Peter K. Sand